Author

D. Compagno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Chauchereau· 1 shared C. Tiraboschi· 1 shared C. Velazquez· 1 shared D. J. Laderach· 1 shared E. Corapi· 1 shared F. M. Jaworski· 1 shared L. Gentilini· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chauchereau

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Galectin-3 as a new negative checkpoint of the immune response is the key target for effective immunotherapy against prostate cancer

C. Tiraboschi, L. Gentilini, E. Corapi, F. M. Jaworski, C. Velazquez, A. Chauchereau, D. J. Laderach, D. Compagno

This paper identifies Galectin-3 as a key immune checkpoint in prostate cancer that Docetaxel inhibits, enhancing immunotherapy effectiveness through Th1 response promotion and CD8+ T cell activation.

bioRxiv · Sep 11, 2019 · PreprintImmunology